Assessment of QT interval and QT dispersion during electroconvulsive therapy using computerized measurements

Journal of ECT

Volumn 26, Issue 1, 2010, Pages 41-46

  Tezuka, Nobuko ^a   Egawa, Hirotoshi ^a   Fukagawa, Daigo ^a   Yamaguchi, Shigeki ^a   Hamaguchi, Shinsuke ^a   Kitajima, Toshimitsu ^a   Minami, Junichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Electroconvulsive therapy; Propofol; QT dispersion; QT interval

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; AMOXAPINE; ARIPIPRAZOLE; BROTIZOLAM; CHLORPROMAZINE; CLOMIPRAMINE; CLOXAZOLAM; ESTAZOLAM; ETIZOLAM; FLUNITRAZEPAM; FLUVOXAMINE; LEVOMEPROMAZINE; LITHIUM; LORAZEPAM; LORMETAZEPAM; MIANSERIN; MILNACIPRAN; NEUROLEPTIC AGENT; NITRAZEPAM; NORTRIPTYLINE; PAROXETINE; PERPHENAZINE; PROPOFOL; QUAZEPAM; QUETIAPINE; RISPERIDONE; SUXAMETHONIUM; TRAZODONE; TRIAZOLAM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BREATHING RATE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ANALYSIS; ELECTROCARDIOGRAM; ELECTROCONVULSIVE THERAPY; ELECTROSTIMULATION; FEMALE; GENERAL ANESTHESIA; HUMAN; MAJOR DEPRESSION; MALE; QT DISPERSION; QT INTERVAL; QT PROLONGATION; RR INTERVAL; THERAPY EFFECT;

ADULT; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; COMPUTERS; ELECTROCARDIOGRAPHY; ELECTROCONVULSIVE THERAPY; FEMALE; HEART RATE; HEART VENTRICLES; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROPOFOL;

EID: 77649287741     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181a95dbe     Document Type: Article

References (34)

1. Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmic risk in patients with long QT intervals. Br Heart J. 1990;63:342-344.
2. Priori SG, Napolitano C, Diehl L, et al. Dispersion of the QT interval: a marker of therapeutic efficacy on the idiopathic long QT interval. Circulation. 1994;89:1681-1689.
3. Lee KW, Okin PM, Kligfield P, et al. Precordial QT dispersion and inducible ventricular tachycardia. Am Heart J. 1997;134: 1005-1013.
4. de Bruyne MC, Hoes AW, Kors JA, et al. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam study. Circulation. 1998;97:467-472.
5. Zareba W, Moss AJ, Le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol. 1994;74:550-553.
6. Glancy JM, Garratt CJ, Woods KL, et al. QT dispersion and mortality after myocardial infarction. Lancet. 1995;345:945-948.
7. Zaidi M, Roberts A, Fesler R, et al. Dispersion of ventricular repolarisation: a marker of ventricular arrhythmias in patients with previous myocardial infarction. Heart. 1997;78:371-375.
8. Dabrowski A, Kramarz E, Piotrowicz R. Dispersion of QT interval following ventricular premature beats and mortality after myocardial infarction. Cardiology. 1999;91:75-80.
9. Okin PM, Devereux RB, Howard BV, et al. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians. The strong heart study. Circulation. 2000;101:61-66.
10. Murakawa Y, Inoue H, Nozaki A, et al. Role of sympathovagal interaction in diurnal variation of QT interval. Am J Cardiol. 1992;39:339-343.
11. Ong JJC, Sarma JSM, Venkataraman K, et al. Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. Am Heart J. 1993;125:744-752.
12. Molnar J, Zhang F, Weiss J, et al. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events. J Am Coll Cardiol. 1996;27:76-83.
13. Ishida S, Nakagawa M, Fujino T, et al. Circadian variation of QT interval dispersion: correlation with heart rate variability. J Electrocardiol. 1997;30:205-210.
14. Nakagawa M, Takahashi N, Iwao T, et al. Evaluation of autonomic influences on QT dispersion using the head-up tilt test in healthy subjects. PACE. 1999;22:1158-1163.
15. Wagner KJ, Möllenberg O, Rentrop M, et al. Guide to anaesthetic selection for electroconvulsive therapy. CNS Drugs. 2005;19: 745-758.
16. McLaughlin NB, Campbell RWF, Murray A. Accuracy of four autonomic QT measurement techniques in cardiac patients and healthy subjects. Heart. 1996;76:422-426.
17. Xue Q, Reddy S. Algorithms for computerized QT analysis. J Electrocardiol. 1998:30(suppl):181-186.
18. Fisch C. Electrocardiography. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia: W.B. Saunders Company; 1997:114.
19. Rowlands DJ. Practical aids in ECG interpretation. In: Rowlands DJ, ed. Clinical Electrocardiography. Philadelphia: Lippincott Company; 1991:263-264.
20. Browne KF, Zipes DP, Heger SS, et al. Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol. 1982;50:1099-1103.
21. Vieweg WVR, Wood MA. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics. 2004;45:371-377.
22. Reilly JG, Ayis SA, Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355:1048-1052.
23. Straus SMJM, Bleumink GS, Dieleman JP, et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med. 2004;164: 1293-1297.
24. Rasmussen KG, Hooten WM, Dodd ML, et al. QTc dispersion on the baseline ECG predicts arrhythmias during electroconvulsive therapy. Acta Cardiol. 2007;62:345-347.
25. Saito S. Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management. J Anesth. 2005;19:142-149.
26. Kleinsasser A, Kuenszberg E, Loeckinger A, et al. Sevoflurane, but not propofol, significantly prolongs the Q-T interval. Anesth Analg. 2000;90:25-27.
27. Rasmussen KG, Laurila DR, Brady BM, et al. Anesthesia outcomes in a randomized double-blind trial of sevoflurane and thiopental for induction of general anesthesia in electroconvulsive therapy. J ECT. 2007;23:236-238.
28. Ramussen KG, Spackman TN, Hooten WM. The clinical utility of inhalation anesthesia with sevoflurane in electroconvulsive therapy. J ECT. 2005;21:239-242.
29. Hodgson RE, Dawson P, Hold AR, et al. Anaesthesia for electroconvulsive therapy: a comparison of sevoflurane with propofol. Anaesth Intensive Care. 2004;32:241-245.
30. Calarge CA, Crowe RR, Gergis SD, et al. The comparative effects of sevoflurane and methohexital for electroconvulsive therapy. J ECT. 2003;19:221-225.
31. Toprak HI, Gedik E, Bege0 Z, et al. Sevoflurane as an alternative anaesthetic for electroconvulsive therapy. J ECT. 2005;21:108-110.
32. Randell T, Tanskanen P, Scheinin M, et al. QT dispersion after subarachnoid hemorrhage. J Neurosurg Anesth. 1999;11: 163-166.
33. Aytemir K, Aksoyek S, Ozer N, et al. QT dispersion and autonomic nervous system function in patients with type 1 diabetes. Int J Cardiol. 1998;65:45-50.
34. Shimabukuro M, Chibana T, Yoshida H, et al. Increased QT dispersion and cardiac adrenergic dysinnervation in diabetic patients with autonomic neuropathy. Am J Cardiol. 1996;78:1057-1059.